The California poppy (Eschscholzia californica Cham.) contains a variety of natural compounds including several alkaloids found exclusively in this plant. Because of the sedative, anxiolytic, and analgesic effects, this herb is currently sold in pharmacies in many countries. However, our understanding of these biological effects at the molecular level is still lacking. Alkaloids detected in E. californica could be hypothesized to act at GABAA receptors, which are widely expressed in the brain mainly at the inhibitory interneurons. Electrophysiological studies on a recombinant α 1 β 2 γ 2 GABAA receptor showed no effect of N-methyllaurotetanine at concentrations lower than 30 μM. However, (S)-reticuline behaved as positive allosteric modulator at the α 3, α 5, and α 6 isoforms of GABAA receptors. The depressant properties of aerial parts of E. californica are assigned to chloride-current modulation by (S)-reticuline at the α 3 β 2 γ 2 and α 5 β 2 γ 2 GABAA receptors. Interestingly, α 1, α 3, and α 5 were not significantly affected by (R)-reticuline, 1,2-tetrahydroreticuline, codeine, and morphine-suspected (S)-reticuline metabolites in the rodent brain.

Department of Biochemistry Faculty of Medicine Masaryk University 62500 Brno Czech Republic

Institute of Biochemistry and Molecular Medicine University of Bern Bühlstrasse 28 3012 Bern Switzerland

Michelin Recherche et Technique S A Route André Piller 30 1762 Givisiez Switzerland

Zobrazit více v PubMed

Schafer H. L., Schafer H., Schneider W., Elstner E. F. Sedative action of extract combinations of Eschscholtzia californica and Corydalis cava . Arzneimittel-Forschung. 1995;45(2):124–126. PubMed

Rolland A., Fleurentin J., Lanhers M.-C., et al. Behavioural effects of the American traditional plant Eschscholzia californica: sedative and anxiolytic properties. Planta Medica. 1991;57(3):212–216. doi: 10.1055/s-2006-960076. PubMed DOI

Rolland A., Fleurentin J., Lanhers M. C., Misslin R., Mortier F. Neurophysiological effects of an extract of Eschscholzia californica Cham. (Papaveraceae) Phytotherapy Research. 2001;15(5):377–381. doi: 10.1002/ptr.884. PubMed DOI

Hanus M., Lafon J., Mathieu M. Double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of a fixed combination containing two plant extracts (Crataegus oxyacantha and Eschscholtzia californica) and magnesium in mild-to-moderate anxiety disorders. Current Medical Research and Opinion. 2004;20(1):63–71. doi: 10.1185/030079903125002603. PubMed DOI

Kardos J., Blaskó G., Simonyi M. Enhancement of gamma-aminobutyric acid receptor binding by protopine-type alkaloids. Arzneimittel-Forschung. 1986;36(6):939–940. PubMed

Häberlein H., Tschiersch K.-P., Boonen G., Hiller K.-O. Chelidonium majus L.: components with in vitro Affinity for the GABAA Receptor. Positive Cooperation of Alkaloids. Planta Medica. 1996;62(3):227–231. doi: 10.1055/s-2006-957865. PubMed DOI

Vacek J., Walterová D., Vrublová E., Šimánek V. The chemical and biological properties of protopine and allocryptopine. Heterocycles. 2010;81(8):1773–1789. doi: 10.3987/REV-10-673. DOI

Şener B., Orhan I. Discovery of drug candidates from some Turkish plants and conservation of biodiversity. Pure and Applied Chemistry. 2005;77(1):53–64. doi: 10.1351/pac200577010053. DOI

Gafner S., Dietz B. M., McPhail K. L., et al. Alkaloids from Eschscholzia californica and their capacity to inhibit binding of [3H]8-hydroxy-2-(di-N-propylamino) tetralin to 5-HT1A receptors in vitro. Journal of Natural Products. 2006;69(3):432–435. doi: 10.1021/np058114h. PubMed DOI

Xu L.-F., Chu W.-J., Qing X.-Y., et al. Protopine inhibits serotonin transporter and noradrenaline transporter and has the antidepressant-like effect in mice models. Neuropharmacology. 2006;50(8):934–940. doi: 10.1016/j.neuropharm.2006.01.003. PubMed DOI

Bugatti C., Colombo M. L., Tomé F. A new method for alkaloid extraction from Chelidonium majus L. Phytochemical Analysis. 1991;2(2):65–67. doi: 10.1002/pca.2800020204. DOI

Suchomelová J., Bochořáková H., Paulová H., Musil P., Táborská E. HPLC quantification of seven quaternary benzo[c]phenanthridine alkaloids in six species of the family Papaveraceae . Journal of Pharmaceutical and Biomedical Analysis. 2007;44(1):283–287. doi: 10.1016/j.jpba.2007.02.005. PubMed DOI

Sigel E. Properties of single sodium channels translated by Xenopus oocytes after injection with messenger ribonucleic acid. Journal of Physiology. 1987;386:73–90. doi: 10.1113/jphysiol.1987.sp016523. PubMed DOI PMC

Fabre N., Claparols C., Richelme S., Angelin M.-L., Fourasté I., Moulis C. Direct characterization of isoquinoline alkaloids in a crude plant extract by ion-pair liquid chromatography-electrospray ionization tandem mass spectrometry: example of Eschscholtzia californica . Journal of Chromatography A. 2000;904(1):35–46. doi: 10.1016/s0021-9673(00)00919-5. PubMed DOI

Rey J.-P., Levesque J., Pousset J.-L., Roblot F. Analytical and quantitative studies of californin and protopin in aerial part extracts of Eschscholtzia californica Cham. with high-performance liquid chromatography. Journal of Chromatography A. 1991;587(2):314–317. doi: 10.1016/0021-9673(91)85174-e. DOI

Tomè F., Colombo M. L., Caldiroli L. A comparative investigation on alkaloid composition in different populations of Eschscholtzia californica Cham. Phytochemical Analysis. 1999;10(5):264–267. doi: 10.1002/(sici)1099-1565(199909/10)10:5lt;264::aid-pca469>3.0.co;2-4. DOI

Verma S. K., Jain V., Verma D., Khamesra R. Cratageus oxycantha—a cardioprotective herb. Journal of Herbal Medicine and Toxicology. 2007;1:65–71.

Goutman J. D., Waxemberg M. D., Doñate-Oliver F., Pomata P. E., Calvo D. J. Flavonoid modulation of ionic currents mediated by GABA(A) and GABA(C) receptors. European Journal of Pharmacology. 2003;461(2-3):79–87. PubMed

Aguirre-Hernández E., Martínez A. L., González-Trujano M. E., Moreno J., Vibrans H., Soto-Hernández M. Pharmacological evaluation of the anxiolytic and sedative effects of Tilia americana L. var. mexicana in mice. Journal of Ethnopharmacology. 2007;109(1):140–145. doi: 10.1016/j.jep.2006.07.017. PubMed DOI

Aguirre-Hernández E., González-Trujano M. E., Martínez A. L., et al. HPLC/MS analysis and anxiolytic-like effect of quercetin and kaempferol flavonoids from Tilia americana var. mexicana . Journal of Ethnopharmacology. 2010;127(1):91–97. doi: 10.1016/j.jep.2009.09.044. PubMed DOI

Martínez A. L., González-Trujano M. E., Aguirre-Hernández E., Moreno J., Soto-Hernández M., López-Muñoz F. J. Antinociceptive activity of Tilia americana var. mexicana inflorescences and quercetin in the formalin test and in an arthritic pain model in rats. Neuropharmacology. 2009;56:564–571. doi: 10.1016/j.neuropharm.2008.10.010. PubMed DOI

Beck M.-A., Häberlein H. Flavonol glycosides from Eschscholtzia californica . Phytochemistry. 1999;50(2):329–332. doi: 10.1016/s0031-9422(98)00503-2. PubMed DOI

Boettcher C., Fellermeier M., Boettcher C., Dräger B., Zenk M. H. How human neuroblastoma cells make morphine. Proceedings of the National Academy of Sciences of the United States of America. 2005;102(24):8495–8500. doi: 10.1073/pnas.0503244102. PubMed DOI PMC

Morais L. C. S. L., Barbosa-Filho J. M., Almeida R. N. Central depressant effects of reticuline extracted from Ocotea duckei in rats and mice. Journal of Ethnopharmacology. 1998;62(1):57–61. doi: 10.1016/s0378-8741(98)00044-0. PubMed DOI

Ziegler J., Facchini P. J., Geißler R., et al. Evolution of morphine biosynthesis in opium poppy. Phytochemistry. 2009;70(15-16):1696–1707. doi: 10.1016/j.phytochem.2009.07.006. PubMed DOI

Nikolaev V. O., Boettcher C., Dees C., Bünemann M., Lohse M. J., Zenk M. H. Live cell monitoring of μ-opioid receptor-mediated G-protein activation reveals strong biological activity of close morphine biosynthetic precursors. Journal of Biological Chemistry. 2007;282(37):27126–27132. doi: 10.1074/jbc.m703272200. PubMed DOI

Laux A., Muller A. H., Miehe M., et al. Mapping of endogenous morphine-like compounds in the adult mouse brain: evidence of their localization in astrocytes and GABAergic cells. Journal of Comparative Neurology. 2011;519(12):2390–2416. doi: 10.1002/cne.22633. PubMed DOI

Freund T. F., Katona I. Perisomatic inhibition. Neuron. 2007;56(1):33–42. doi: 10.1016/j.neuron.2007.09.012. PubMed DOI

Beneyto M., Lewis D. A. Insights into the neurodevelopmental origin of schizophrenia from postmortem studies of prefrontal cortical circuitry. International Journal of Developmental Neuroscience. 2011;29(3):295–304. doi: 10.1016/j.ijdevneu.2010.08.003. PubMed DOI PMC

Zhu W., Ma Y., Cadet P., et al. Presence of reticuline in rat brain: a pathway for morphine biosynthesis. Molecular Brain Research. 2003;117(1):83–90. doi: 10.1016/s0169-328x(03)00323-1. PubMed DOI

Laux-Biehlmann A., Mouheiche J., Vérièpe J., Goumon Y. Endogenous morphine and its metabolites in mammals: history, synthesis, localization and perspectives. Neuroscience. 2013;233:95–117. doi: 10.1016/j.neuroscience.2012.12.013. PubMed DOI

Cahlíková L., Hulová L., Hrabinová M., et al. Isoquinoline alkaloids as prolyl oligopeptidase inhibitors. Fitoterapia. 2015;103:192–196. doi: 10.1016/j.fitote.2015.04.004. PubMed DOI